Señales en vivo de LIDDS.ST | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (6 may 2024 @ 09:54):

LIDDS AB (publ), a pharmaceutical company, develops and sells pharmaceutical products for cancer and other diseases in Sweden. It is developing various drugs, such as NZ-2HOF to treat prostate cancer; NZ-DTX to treat breast, prostate, head, neck, stomach, and lung cancer; NZ-DOX for the treatment of solid tumors; NZ-IO, an immunotherapy; NZ-STING for the treatment of immuno-oncology; and NZ-TLR9 for enhancing cancer immunotherapies...

Stats
Volumen de hoy	50 000.00
Volumen promedio	93 805.00
Capitalización de mercado	11.80M
EPS	SEK0 ( 2024-02-21 )
Próxima fecha de ganancias	( SEK0 ) 2024-05-27
Last Dividend	SEK0 ( N/A )
Next Dividend	SEK0 ( N/A )
P/E	-0.290
ATR14	SEK0.00200 (1.16%)

LIDDS AB (publ) Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

LIDDS AB (publ) Finanzas

Annual	2023
Ingresos:	SEK0
Beneficio Bruto:	SEK-15.69M (0.00 %)
EPS:	SEK-0.630

FY	2023
Ingresos:	SEK0
Beneficio Bruto:	SEK-15.69M (0.00 %)
EPS:	SEK-0.630

FY	2023
Ingresos:	SEK0
Beneficio Bruto:	SEK0 (0.00 %)
EPS:	SEK0

FY	2022
Ingresos:	SEK1.89M
Beneficio Bruto:	SEK-36.62M (-1 939.62 %)
EPS:	SEK-1.000

Financial Reports:

No articles found.

LIDDS AB (publ)